You have 9 free searches left this month | for more free features.

Phase 1 Dose Escalation

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

Not yet recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • FluBHPVE6E7
  • Placebo
  • (no location specified)
Apr 24, 2023

Ovarian Cancer Trial in Lexington (Artemisia annua 450mg, Artemisia annua 900mg, Artemisia annua 1350mg)

Recruiting
  • Ovarian Cancer
  • Artemisia annua 450mg
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Jan 4, 2023

Pain Trial in Harrow (VX-973, Placebo, Midazolam)

Recruiting
  • Pain
  • Harrow, United Kingdom
    PAREXEL International
May 17, 2023

Tumors Malignant Trial in Shanghai (AK117)

Active, not recruiting
  • Neoplasms Malignant
  • Shanghai, Shanghai, China
    FuDan University Shanghai Cancer Center
Oct 8, 2022

Solid Tumors Trial in Houston (Rimiducid, TROP2-CAR-NK Cells, Fludarabine phosphate)

Not yet recruiting
  • Solid Tumors
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Trial in La Jolla, Philadelphia (RP-A601)

Not yet recruiting
  • PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
  • RP-A601
  • La Jolla, California
  • +1 more
May 22, 2023

Advanced / Metastatic Solid Tumor Trial (SR-8541A)

Not yet recruiting
  • Advanced / Metastatic Solid Tumor
  • (no location specified)
Oct 3, 2023

Solid Tumor, Adult Trial in Belgium, France (DT-9081 - dose escalation, DT-9081 - expansion)

Recruiting
  • Solid Tumor, Adult
  • DT-9081 - dose escalation
  • DT-9081 - expansion
  • Anderlecht, Belgium
  • +3 more
Jan 5, 2023

Pain Trial in Manchester (VX-993, Placebo)

Recruiting
  • Pain
  • Manchester, United Kingdom
    MAC Clinical Research
Jan 6, 2023

Corneal Epithelial Degeneration Trial in Cypress (TTHX1114(NM141) Ophthalmic Solution)

Recruiting
  • Corneal Epithelial Degeneration
  • TTHX1114(NM141) Ophthalmic Solution
  • Cypress, California
    Trefoil Clinical Site #132
Mar 3, 2023

Cachexia Trial (AV-380)

Not yet recruiting
  • Cachexia
  • AV-380
  • (no location specified)
May 9, 2023

Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, High-risk Myelodysplastic Syndrome Trial (VIP943)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
Sep 5, 2023

Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Irvine, Chicago, Boston

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Irvine, California
  • +2 more
Nov 27, 2023

Tumors Trial in San Antonio (VIP236)

Recruiting
  • Neoplasms
  • San Antonio, Texas
    NEXT Oncology San Antonio
Feb 3, 2023

Solid Tumor Trial (TXN10128)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Jul 29, 2023

Advanced Solid Tumors Trial in Hangzhou (ZGGS15)

Not yet recruiting
  • Advanced Solid Tumors
  • ZGGS15
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 17, 2023

Advanced Solid Tumors Trial (ASKG915)

Not yet recruiting
  • Advanced Solid Tumors
  • ASKG915
  • (no location specified)
May 10, 2023

Advanced Solid Tumor Trial in Seongnam, Seoul (ABL103)

Recruiting
  • Advanced Solid Tumor
  • Seongnam, Seoul, Korea, Republic of
  • +2 more
Nov 13, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)

Not yet recruiting
  • Advanced Solid Tumor
  • ZG0895 Hydrochloride for Injection
  • (no location specified)
May 25, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Advanced Solid Tumors Trial (ASKG315)

Not yet recruiting
  • Advanced Solid Tumors
  • ASKG315
  • (no location specified)
Aug 18, 2022

APOL1-mediated Kidney Disease Trial in Lenexa (VX-840, Placebo)

Completed
  • APOL1-mediated Kidney Disease
  • Lenexa, Kansas
    ICON Lenexa
Dec 6, 2022

Advanced Solid Tumors Trial (ASKG315)

Not yet recruiting
  • Advanced Solid Tumors
  • ASKG315
  • (no location specified)
Sep 22, 2022

Acute Pain Trial in Manchester (VX-708, Placebo)

Recruiting
  • Acute Pain
  • Manchester, United Kingdom
    MAC Clinical Research
Apr 20, 2022